MX2010003045A - Cyclosporin compositions. - Google Patents

Cyclosporin compositions.

Info

Publication number
MX2010003045A
MX2010003045A MX2010003045A MX2010003045A MX2010003045A MX 2010003045 A MX2010003045 A MX 2010003045A MX 2010003045 A MX2010003045 A MX 2010003045A MX 2010003045 A MX2010003045 A MX 2010003045A MX 2010003045 A MX2010003045 A MX 2010003045A
Authority
MX
Mexico
Prior art keywords
cyclosporin compositions
compositions
cyclosporin
cyclosporine
disclosed
Prior art date
Application number
MX2010003045A
Other languages
Spanish (es)
Inventor
Walter L Tien
Richard S Graham
Aileen Morgan
Mayssa Attar
Rhett Schiffman
David A Hollander
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2010003045A publication Critical patent/MX2010003045A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

Disclosed herein are therapeutic methods, compositions, and medicaments related to cyclosporine.
MX2010003045A 2007-09-20 2008-09-18 Cyclosporin compositions. MX2010003045A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/858,200 US20080146497A1 (en) 2006-07-25 2007-09-20 Cyclosporin Compositions
PCT/US2008/076756 WO2009099467A2 (en) 2007-09-20 2008-09-18 Cyclosporin compositions

Publications (1)

Publication Number Publication Date
MX2010003045A true MX2010003045A (en) 2010-04-29

Family

ID=39528114

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003045A MX2010003045A (en) 2007-09-20 2008-09-18 Cyclosporin compositions.

Country Status (12)

Country Link
US (1) US20080146497A1 (en)
EP (1) EP2190407B1 (en)
JP (1) JP2010540446A (en)
KR (1) KR20100091946A (en)
CN (1) CN101835463A (en)
AU (1) AU2008349774A1 (en)
BR (1) BRPI0816995A2 (en)
CA (1) CA2700182A1 (en)
IL (1) IL204614A0 (en)
MX (1) MX2010003045A (en)
RU (1) RU2010112472A (en)
WO (1) WO2009099467A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US8435544B2 (en) 2007-10-08 2013-05-07 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
WO2010127301A1 (en) * 2009-05-01 2010-11-04 Allergan, Inc. Method of treating allergic conjunctivitis with cyclosporin compositions
ES2537385T3 (en) * 2009-06-09 2015-06-08 Aurinia Pharmaceuticals Inc. Topical supply systems for ophthalmic use
RU2014129268A (en) * 2011-12-16 2016-02-10 Аллерган, Инк. OPHTHALMIC COMPOSITIONS THAT CONTAIN GRAVITY POLYVINYL POLYVINYL PROCALT-POLYVINYL ACETATE-POLYETHYLENE Glycol copolymers
FR2988297B1 (en) * 2012-03-22 2014-03-28 Thea Lab AQUEOUS OPHTHALMIC SOLUTION FROM CICLOSPORINE WITHOUT PRESERVATIVE
CN104487449A (en) 2012-06-01 2015-04-01 阿勒根公司 Cyclosporin A analogs
CA2955037A1 (en) * 2014-07-18 2016-01-21 Allergan, Inc. Suspension compositions of cyclosporin a for subconjunctival and periocular injection
KR101587412B1 (en) * 2014-10-17 2016-01-21 주식회사 휴온스 Ophthalmic Composition Comprising Cyclosporine and Trehalose
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
RU2762767C1 (en) * 2020-09-15 2021-12-22 Федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Министерства здравоохранения Российской Федерации Method for determining the corneal tactile sensitivity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2577049B2 (en) * 1987-06-04 1997-01-29 三共株式会社 Cyclosporine preparation
DE3851152T2 (en) * 1987-09-03 1995-01-26 Univ Georgia Res Found CYCLOSPORINE EYE PRODUCTS.
ES2098739T3 (en) * 1992-05-13 1997-05-01 Sandoz Ltd OPHTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN.
BR0112461A (en) * 2000-07-14 2003-07-22 Allergan Inc Compositions containing therapeutically active components having increased solubility
AU2006270041B2 (en) * 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
NZ568694A (en) * 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions

Also Published As

Publication number Publication date
IL204614A0 (en) 2010-11-30
AU2008349774A1 (en) 2009-08-13
BRPI0816995A2 (en) 2015-03-24
EP2190407A2 (en) 2010-06-02
WO2009099467A3 (en) 2009-10-22
CN101835463A (en) 2010-09-15
WO2009099467A2 (en) 2009-08-13
RU2010112472A (en) 2011-10-27
CA2700182A1 (en) 2009-08-13
JP2010540446A (en) 2010-12-24
EP2190407B1 (en) 2016-12-07
KR20100091946A (en) 2010-08-19
US20080146497A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
MX2010003045A (en) Cyclosporin compositions.
WO2008014200A3 (en) Cyclosporin compositions
WO2010054266A3 (en) Multiblock copolymers
IN2012DN00548A (en)
IN2012DN00746A (en)
TN2012000414A1 (en) Forms of rifaximin and uses thereof
MX344786B (en) Compositions and methods for treating gaucher disease.
MX2019000225A (en) Compositions and methods for treatment of autoimmune and other disease.
ZA200807274B (en) Novel pyridine derivatives
MY181898A (en) Heterocyclic compounds and uses thereof
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
TN2012000611A1 (en) Formulations of rifaximin and uses thereof
MX2011011950A (en) Sublingual dexmedetomidine compositions and methods of use thereof.
TN2011000172A1 (en) Therapeutic antiviral peptides
MY146112A (en) Long-term feed - cancer patient
MX2014004862A (en) Acrylic polymer formulations.
MX2013004061A (en) Cyclosporin analogs.
MX2010001865A (en) Personal care compositions comprising dye-polymer complexes.
MX2013000642A (en) Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators.
MX2010000593A (en) Increasing plant vigor.
GB2461659A (en) Structured compositions comprising a clay
TW200942530A (en) Pyridine compounds
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
MX2009010689A (en) Novel formulations for delivery of antiviral peptide therapeutics.
WO2012061390A3 (en) Therapeutic compositions and methods

Legal Events

Date Code Title Description
FA Abandonment or withdrawal